Healthtech Startups

Nebuflow develops drug delivery technology for pharmaceutical applications. The company focuses on transforming how life-changing drugs are delivered.

2 investors

Nektar develops therapies that modulate the immune system to treat autoimmune diseases and inflammatory conditions, targeting the root causes of immune dysfunction. The company conducts research, therapeutic discovery, and clinical development, working with pharmaceutical partners to bring immune-mediated disease treatments to patients.

2 investors

NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.

2 investors

Neopathology develops tissue diagnostic assays and a proprietary platform called ONEPATHOLOGY that delivers rapid, accurate disease diagnosis and patient stratification for precision medicine treatments. The company combines spatial biology and deep-tissue profiling technologies to standardize tissue diagnostics.

2 investors

2 investors

Nephrolyx develops the IVDx system, combining an IVD kit with GFRx software that integrates into laboratory LIMS to measure glomerular filtration rate (mGFR) via iohexol plasma clearance for kidney function diagnostics in clinical routine. It serves physicians, clinical laboratories, and pharma/biotech companies conducting kidney research, and also offers the DNPx digital platform for research use.

2 investors

NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair. It maintains a drug pipeline and operates as a publicly traded company.

2 investors

NĒRx Biosciences develops small molecule inhibitors targeting DNA damage sensor proteins for cancer treatment, with initial focus on difficult-to-treat lung and ovarian cancers. The company builds on two decades of academic research from Indiana University's School of Medicine on DNA damage and repair mechanisms.

2 investors

Nesa Medtech develops GYIDE, a minimally invasive, uterus-preserving medical device that uses a guidance and planning system to deliver treatment that shrinks uterine fibroids without cutting or suturing. The company targets women's health, offering an alternative to existing surgical and non-surgical treatments for uterine fibroids.

2 investors

Neulife Rehab provides rehabilitation services for people recovering from catastrophic illness or injury. It focuses on supporting patients through the next steps of their recovery.

2 investors

Neuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.

2 investors

Neuraura Biotech develops proprietary 3D micro-electrode and microsensor technology for high-fidelity neural recording and percutaneous stimulation, used to improve diagnostic and therapeutic solutions for neurological, psychiatric and sensory conditions. The company commercializes technology transferred from the University of Calgary, with a stated focus on chronic, underserved health conditions including women's health.

2 investors

NeuraWorx is developing a wearable bioelectronic stimulator based on its Cerebrovascular Pacing System, intended for sale after clinical study and FDA clearance. The device is a neurostimulation medical technology in early development.

2 investors

neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility. The system supports point-of-care diagnosis and image-guided, minimally invasive neurological procedures for physicians and patients.

2 investors

Neurobell develops AI-powered medical technology for continuous monitoring of neonatal brain activity in neonatal intensive care units. The company combines clinical expertise with machine learning to advance neonatal brain monitoring capabilities.

2 investors

neurocare group operates a network of over 20 clinics across Europe, the United States, and Australia offering personalized mental health treatments such as TMS, neurofeedback, and tDCS for conditions including depression, ADHD, OCD, and sleep disorders. It also provides a Digital Therapy Platform and an online academy that trains third-party clinicians in its treatment protocols.

2 investors

Neuroglee provides remote dementia and memory care through a care team of navigators, clinicians, social workers, and pharmacists who coordinate treatment, offer 24/7 support, and connect patients and caregivers with community resources. It also helps manage other long-term conditions and serious illnesses for patients and their families at home.

2 investors

Neurogram develops AI-powered solutions for neurological diagnostics using brain-computer interface technology and EEG analysis. The company serves neurologists and healthcare providers seeking precision diagnostic tools grounded in neuroscience research.

2 investors

Neuroharmonics is developing a non-invasive neuromodulation platform based on focused transcranial ultrasound to modulate specific brain circuits for treating neurological and psychiatric conditions and enabling brain-computer interaction. The company operates in the neurotech and medical technology space.

2 investors

NeuroIntact develops VCool, a portable system for precise core body temperature modulation in hospitalized patients. The company serves clinical markets including military and commercial hospitals, operating in the medical device and healthcare technology sector.

2 investors

Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.

2 investors

Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness. The system pairs a non-invasive EEG headset, a thought-controlled wireless handpiece, and a tablet to guide and track therapy.

2 investors

Neuromod is a medical technology company that developed Lenire, an FDA-approved bimodal neuromodulation device for treating tinnitus. Its device is available through clinics across Europe and the United States and has been studied in large-scale clinical trials.

2 investors

NeuroSonic develops a handheld, non-invasive device that assesses stroke risk by analyzing carotid artery blood flow, enabling clinicians to determine which patients require further vascular imaging. The device is designed for use in clinical settings to accelerate stroke-risk assessment and improve prevention.

2 investors